Patently problematic

The Indian patent office’s ruling on the grant of the first compulsory licence to the generic drug firm Natco on liver and kidney cancer drug ‘Nexavar’ came about nine days after a grand announcement from the Prime Minister’s Office endorsing a health ministry initiative to distribute free essential medicine to all through public health facilities. The Cabinet has already approved the setting up of a Central Procurement Agency for the bulk procurement of drugs.

Read Full Story>>